Cargando…

Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1

Temporal lobe epilepsy (TLE) is the most common focal seizure disorder in adults. In many patients, transient brain insults, including status epilepticus (SE), are followed by a latent period of epileptogenesis, preceding the emergence of clinical seizures. In experimental animals, transcriptional u...

Descripción completa

Detalles Bibliográficos
Autores principales: van Loo, Karen M. J., Schaub, Christina, Pitsch, Julika, Kulbida, Rebecca, Opitz, Thoralf, Ekstein, Dana, Dalal, Adam, Urbach, Horst, Beck, Heinz, Yaari, Yoel, Schoch, Susanne, Becker, Albert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846312/
https://www.ncbi.nlm.nih.gov/pubmed/26498180
http://dx.doi.org/10.1038/ncomms9688
Descripción
Sumario:Temporal lobe epilepsy (TLE) is the most common focal seizure disorder in adults. In many patients, transient brain insults, including status epilepticus (SE), are followed by a latent period of epileptogenesis, preceding the emergence of clinical seizures. In experimental animals, transcriptional upregulation of Ca(V)3.2 T-type Ca(2+)-channels, resulting in an increased propensity for burst discharges of hippocampal neurons, is an important trigger for epileptogenesis. Here we provide evidence that the metal-regulatory transcription factor 1 (MTF1) mediates the increase of Ca(V)3.2 mRNA and intrinsic excitability consequent to a rise in intracellular Zn(2+) that is associated with SE. Adeno-associated viral (rAAV) transfer of MTF1 into murine hippocampi leads to increased Ca(V)3.2 mRNA. Conversely, rAAV-mediated expression of a dominant-negative MTF1 abolishes SE-induced Ca(V)3.2 mRNA upregulation and attenuates epileptogenesis. Finally, data from resected human hippocampi surgically treated for pharmacoresistant TLE support the Zn(2+)-MTF1-Ca(V)3.2 cascade, thus providing new vistas for preventing and treating TLE.